Jun 12, 2014 02:07 PM EDT
Shire Agrees to FDA Request to Test ADHD Medication on Preschool Children
Shire, a global innovator in specialty biopharmaceuticals, announced today that they will conduct clinical trials using their amphetamine-based drug, Vyvanse, on preschool children with attention deficit hyperactivity disorder (ADHD).